Editorial: Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease-Reference-Cited by-同舟云学术

Editorial: Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease

Published:2014-02-25 Issue:3 Volume:66 Page:485-487
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Silver Richard M.¹,Feghali-Bostwick Carol A.¹

Affiliation:

1. Medical University of South Carolina; Charleston

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38287/fullpdf

Reference14 articles.

1. Association of interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis;Christmann;Arthritis Rheumatol,2014

2. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007

3. Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis;Daoussis;Clin Exp Rheumatol,2012

4. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study placebo group;Khanna;Arthritis Rheum,2011

5. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung involvement in systemic sclerosis;Handbook of Systemic Autoimmune Diseases;2022

2. Major lung complications of systemic sclerosis;Nature Reviews Rheumatology;2018-08-15

3. Myeloid Populations in Systemic Autoimmune Diseases;Clinical Reviews in Allergy & Immunology;2017-05-20

4. Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?;Current Rheumatology Reports;2015-12-23

5. Management of Systemic-Sclerosis-Associated Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2015-08